Linda Lam | USC Profiles

Linda Lam, MD

Title(s)	Associate Professor of Clinical Ophthalmology
School	Keck School of Medicine of USC
Phone	+1 626 446 2122
vCard	Download vCard

Other Positions


Title(s)	Vice Chair For Satellite Clinics in The Department of Ophthalmology
Title(s)	Medical Director, Arcadia

Biography

Education and Training

Brown University	BS, honors
Cornell University Medical College	MD
USC Marshall School of Business	MBA, honors
Cleveland Clinic Foundation	Ophthalmology Residency
Georgetown University Hospital/ Retina Group of Washington	Medical and Surgical Vitreoretinal Fellowship

Awards and Honors

Pasadena Magazine			Top Doctor
USC Department of Ophthalmology			Highest Patient Satisfaction Score, Press-Ganey Survey
			Cornell University Medical College Award for Honors in Research
			American Heart Association Research Fellowship
			Dilmaghani Medical Scholarship
			David S. Barr Research Fellowship
			NIH Summer Training Grant Fellowship
			Tai Foundation Medical Scholarship
Brown University			Sigma Xi Award
			Class of 1993 Brown University Scholar
			Soroptimist Foundation Scholarship for Community Leadership

Overview

Linda A. Lam, MD, MBA, is the vice chair of Satellite Clinical Affairs and an associate professor in ophthalmology at the Keck School of Medicine of USC. She was educated at Brown University where she graduated with honors in Neuroscience. Dr. Lam received her medical degree with honors at Cornell University Medical College, where she also completed a research fellowship on retinal cell physiology. She completed her residency at the Cole Eye Institute at Cleveland Clinic, before her fellowship appointment at Georgetown University Hospital and the Retina Group of Washington. She serves as a reviewer for journals including Ophthalmology and British Journal of Ophthalmology. Dr. Lam has authored peer-reviewed journal articles and book chapters in retinal diseases. She has lectured both internationally and nationally on retinal disease and research. She also serves as the medical director of USC Roski Eye Institute Arcadia. She also is a graduate of the executive MBA program at the Marshall School of Business. Dr. Lam is also an executive board member at the Braille Institute of America. Her research interests include macular degeneration, diabetic retinopathy, complex vitreoretinal surgery, and innovative technology to aid blind and low vision individuals.

ORNG Applications

Websites

Featured Videos

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Roboz GJ, Ritchie EK, Dault Y, Lam L, Marshall DC, Cruz NM, Hsu HC, Hassane DC, Christos PJ, Ippoliti C, Scandura JM, Guzman ML. Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia. Haematologica. 2018 Aug; 103(8):1308-1316. PMID: 29724902.

View in: PubMed
Storey PP, Aziz HA, O'Keefe GAD, Borchert M, Lam LA, Puliafito CA, Olmos de Koo LC. Decreased severity of age-related macular degeneration in amblyopic eyes. Br J Ophthalmol. 2018 Nov; 102(11):1575-1578. PMID: 29437581.

View in: PubMed
Cruz NM, Sugita M, Ewing-Crystal N, Lam L, Galetto R, Gouble A, Smith J, Hassane DC, Roboz GJ, Guzman ML. Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia. Leuk Lymphoma. 2018 04; 59(4):978-982. PMID: 28795850.

View in: PubMed
Galletti G, Leach BI, Lam L, Tagawa ST. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer. Cancer Treat Rev. 2017 Jun; 57:16-27. PMID: 28527407.

View in: PubMed
Lam LA.Retina,. Angioid Streaks. 2017.
Vlachostergios PJ, Galletti G, Palmer J, Lam L, Karir BS, Tagawa ST. Antibody therapeutics for treating prostate cancer: where are we now and what comes next? Expert Opin Biol Ther. 2017 02; 17(2):135-149. PMID: 27817214.

View in: PubMed
Hariri A, Diniz B, Fou LV, Lam LA, Nittala MG, Sadda SR. Quantitative OCT subanalysis of eyes with choroidal neovascularization switched from multiple injections of bevacizumab or ranibizumab to intravitreal aflibercept. Ophthalmic Surg Lasers Imaging Retina. 2015 Feb; 46(2):195-200. PMID: 25707044.

View in: PubMed
Lam LA, Rodger DC. Bilateral macular detachments, venous stasis retinopathy, and retinal hemorrhages as initial presentation of multiple myeloma: a case report. Retin Cases Brief Rep. 2014; 8(4):240-4. PMID: 25372517.

View in: PubMed
Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina. 2012 Oct; 32(9):1915-41. PMID: 22863970.

View in: PubMed
Lam LA.Retina. Angioid Streaks. 2012.
Gasperini JL, Fawzi AA, Khondkaryan A, Lam L, Chong LP, Eliott D, Walsh AC, Hwang J, Sadda SR. Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation. Br J Ophthalmol. 2012 Jan; 96(1):14-20. PMID: 21791509.

View in: PubMed
Lam LA.Curbside Consultation in Retina. How Long Should I Wait to Perform Cataract Surgery after Treatment of Diabetic Macular Edema or Retinopathy?. 2010; 29 - 33.
Murphy RP, Lam LA, Chew EY.Retina. Hypertension. 2005; 1377-82.
Lam LA, Lowder CY, Baerveldt G, Smith SD, Traboulsi EI. Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol. 2003 Jun; 135(6):772-8. PMID: 12788115.

View in: PubMed
Li Y, Lam LA, Yu Z, Yang Z, Bither P, Zhang K.Clinical Spectrum in Autosomal Dominant Stargardt's Macular Dystrophy with a Mutation in ELOVL4 gene. 2001.
Erkan D, Lam LA, Yazici Y, Magid SK. A case of VATER association mimicking spondylarthropathy. Clin Exp Rheumatol. 2000 Sep-Oct; 18(5):651. PMID: 11072616.

View in: PubMed
Marmorstein AD, Csaky KG, Baffi J, Lam L, Rahaal F, Rodriguez-Boulan E. Saturation of, and competition for entry into, the apical secretory pathway. Proc Natl Acad Sci U S A. 2000 Mar 28; 97(7):3248-53. PMID: 10725401; PMCID: PMC16224.

View in: PubMed, PubMed Central